Immunological alterations and associated diseases in mandrills (Mandrillus sphinx) naturally co-infected with SIV and STLV  by Souquière, Sandrine et al.
Immunological alterations and associated diseases in mandrills
(Mandrillus sphinx) naturally co-infected with SIV and STLV
Sandrine Souquière a, Maria Makuwa a, Bettina Sallé b,1, Yves Lepelletier d,
Franck Mortreux e, Olivier Hermine d, Mirdad Kazanji a,c,n
a Laboratoire de Rétrovirologie, Centre International de Recherches Médicales de Franceville, Franceville, Gabon
b Centre de Primatologie, Centre International de Recherches Médicales de Franceville, Franceville, Gabon
c Réseau International des Instituts Pasteur, Institut Pasteur, Paris, France
d Département d'Hématologie, Hôpital Necker, Paris, France
e Université de Lyon 1, CNRS UMR5239, Oncovirologie et Biothérapies, Faculté de Médecine Lyon Sud, Pierre Bénite, France
a r t i c l e i n f o
Article history:
Received 22 November 2013
Returned to author for revisions
16 January 2014
Accepted 18 February 2014
Available online 7 March 2014
Keywords:
SIV
STLV
Co-infection
Associated diseases
Viral load
Cell line
Immune system
Mandrillus sphinx
a b s t r a c t
Mandrills are naturally infected with simian T-cell leukaemia virus type 1 (STLV-1) and simian
immunodeﬁciency virus (SIV)mnd. In humans, dual infection with human immunodeﬁciency virus
(HIV) and human T-cell lymphotropic virus type 1 (HTLV-1) may worsen their clinical outcome. We
evaluated the effect of co-infection in mandrills on viral burden, changes in T-cell subsets and clinical
outcome. The SIV viral load was higher in SIV-infected mandrills than in co-infected animals, whereas
the STLV-1 proviral load was higher in co-infected than in mono-infected groups. Dually infected
mandrills had a statistically signiﬁcantly lower CD4þ T-cell count, a lower proportion of naive CD8þ T
cells and a higher proportion of central memory cells. CD4þ and CD8þ T cells from SIV-infected animals
had a lower percentage of Ki67 than those from the other groups. Co-infected monkeys had higher
percentages of activated CD4þ and CD8þ T cells. Two co-infected mandrills with high immune activation
and clonal integration of STLV provirus showed pathological manifestations (infective dermatitis and
generalised scabies) rarely encountered in nonhuman primates.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Human T-cell lymphotropic virus type 1 (HTLV-1), the causative
agent of adult T-cell leukaemia/lymphoma (Yoshida, 1983) and of
tropical spastic paraparesis/HTLV-1-associated myelopathy (Gessain
et al., 1985), has also been implicated in other inﬂammatory diseases,
such as paediatric infectious dermatitis (Lagrenade et al., 1990),
uveitis (Mochizuki et al., 1992), arthropathy (Ijichi et al., 1990) and
polymyositis (Morgan et al., 1989). It was reported previously that co-
infection with other pathogens, such as parasites (e.g. Strongloides) or
human immunodeﬁciency virus type 1 (HIV-1), affects the develop-
ment of disease (Carvalho and Da Fonseca Porto, 2004; Casoli et al.,
2007). Cohort studies of people co-infected with HIV-1 and HTLV-1
showed that they are at higher risk for more rapid development of
more aggressive AIDS than people infected solely with HIV, with
important implications for the progression and severity of HIV-
related disease (Beilke et al., 2005; Casoli et al., 2007). It has also
been reported that co-infection with HIV-1 and HTLV-1 accelerates
diseases associated with HTLV-1 infection (Beilke et al., 2005; Casseb
et al., 2008).
Simian T cell leukaemia virus type 1 (STLV-1), the simian
counterpart of HTLV-1, naturally infects Old World monkeys and
shares virological, immunological, molecular and pathological
features with HTLV-1 (Gessain et al., 1996; Hayami et al., 1985;
Saksena et al., 1994). Natural STLV-1 infection has been associated
with the development of diseases related to adult T-cell leukae-
mia/lymphoma, in some cases with co-infection with SIV. For
example, neoplastic diseases in sooty mangabeys (Fultz et al.,
1997) and lymphoproliferative disease in African green monkeys
(Traina-Dorge et al., 1992) were found in animals naturally co-
infected with STLV-1 and SIV. Furthermore, experimental co-
infection of rhesus and pigtailed macaques with the two viruses
(Fultz et al., 1999; McGinn et al., 2002; Traina-Dorge et al., 2007)
led to a pre-leukaemic condition in a few animals. These ﬁndings
provide support for clinical observations in humans that HIV–
HTLV co-infection may up-regulate cell proliferation and HTLV-1
expression and increase disease potential.
We showed recently that STLV-1 infection induces immune
activation and increased proliferation of T cells in mandrills,
suggesting that STLV-1 infection can induce T-cell activation and
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transformation and that this activation might be related to a high
proviral load (Souquiere et al., 2009b). These observations are the
ﬁrst in monkeys naturally infected with STLV-1 in the wild. There
was, however, no clinical manifestation or associated illness in
these naturally infected mandrills. This species of monkeys has
also been shown to be naturally infected with SIVmnd (Souquiere
et al., 2001; Tsujimoto et al., 1989), but the infection does not
appear to induce AIDS, despite a high plasma viral load (Onanga
et al., 2002; Onanga et al., 2006). Recently, a functional phenotypic
study of lymphocyte populations in SIV-infected mandrills showed
limited activation and preserved immune regenerative capacity
(Apetrei et al., 2011). Several studies have been conducted on SIV
and STLV infections in nonhuman primates (Apetrei et al., 2011;
Gabet et al., 2003; Souquiere et al., 2009a; Souquiere et al., 2009b;
Sumpter et al., 2007), but none has explored SIV–STLV co-infection
in mandrills.
Natural co-infection of mandrills with both STLV-1 and SIV is a
suitable model for studying the host–virus interaction and the role
of co-infection in viral dynamics, immune system disruption and
disease progression. We therefore followed up, characterised and
compared infections and their effects on the immune system in
four populations of mandrills: STLV-infected, SIV-infected, SIV–
STLV co-infected and uninfected controls.
Results
Co-infection
Four groups of mandrills were selected according to the
serological results (Table 1): a control group of 58 mandrills
uninfected with SIV or STLV; 38 mandrills infected with SIVmnd-
1 or SIVmnd-2 (SIVþ); 19 mandrills infected with STLV-1 subtype
D (STLVþ); and 13 mandrills infected with both SIVmnd-1 and
STLV-1 subtype D (SIVþ/STLVþ). The mean ages of each group
were 1076 years (range, 5–28) for controls, 1275 years (3–23)
for SIVþ , 1275 years (4–19) for STLVþ and 1375 years (6–20)
for SIVþ/STLVþ .
Two co-infected mandrills showed severe immune perturbation and
disease
Two of the mandrills naturally co-infected with SIVmnd type
1 and STLV-1 had clinical signs that might have been related to the
retroviral infections (Table 2). Mandrill T was a 12-year-old male,
and, from data obtained during annual health examinations, we
estimated that the duration of infection was 3 years for SIV and
5 years for STLV. Mandrill A was a 20-year-old male; the duration
of infection could not be estimated, because it had been infected in
the wild. Mandrill T had infective dermatitis, and mandrill A had
generalised scabies (Fig. 1A and B), both conditions being resistant
to treatment for several months. Blood smears showed the pre-
sence of ﬂower cells in both animals and persistent hypereosino-
philia in mandrill A (44800/mm3).
In terms of virus replication, no difference from controls was
found in SIV viral load, but the STLV proviral load was higher than
any previously registered in mandrills: mandrill T had 22.5 copies
of STLV per 100 PBMC and mandrill A, 42.6. We have shown that
STLV can infect CD4þ and CD8þ cells, and we therefore quantiﬁed
the proviral load in these two compartments. Similar results were
found in the two mandrills, which had the highest values ever
recorded: mandrill T had 23.8% copies of STLV-1 in CD4þ T cells
and 35.3% in CD8þ T cells, and mandrill A had a proviral load of
74.7% in CD4þ T cells and 33.5% in CD8þ cells.
We next examined the effects of the dual viral burden on
immunological parameters. The absolute numbers of CD4þ T cells
in blood were 224/mm3 in mandrill T and 184/mm3 in mandrill A;
these values were in the normal range for the 58 uninfected
mandrills. In contrast, remarkable differences were found in terms
of immune activation. As shown in Table 2, activation of CD4þ and
CD8þ T cells measured by expression of HLA-DR was 3–16 times
higher than in the uninfected population. Conﬁrmation of this
result was found in the expression of CD25 in CD4þ and CD8þ T
cells. Proliferation, evaluated from expression of Ki67, was
increased only in mandrill A, but the proliferative capacity (13.5%
in CD4þ and 13.1% in CD8þ T cells) was highly unusual.
Il-2, IFN-γ, TNF-α, IL-4, IL-6 and IL-10 were quantiﬁed in plasma
from these two mandrills. No signiﬁcant differences from the values
for 21 uninfected mandrills were observed (Table 2), except that the
level of TNF-α in mandrill T, which had infective dermatitis, was
three times higher than the average value in uninfected animals.
It is of note that, in humans, infective dermatitis was recently
associated with an increase in TNF-α (Nascimento et al., 2009).
Dynamics of viral loads
To explore the inﬂuence of co-infection on the dynamics of the
viral load, we measured the SIVmnd plasma viral load and the
STLV-1 proviral load in the three infected groups, as described
previously (Onanga et al., 2002; Onanga et al., 2006; Souquiere
et al., 2009a; Souquiere et al., 2009c). As seen in Fig. 2A, the mean
of viral load in SIVþ mandrills was somewhat higher (mean,
3.6106 copies/ml; range, 3.7104–2.5107) than in SIVþ/
STLVþ animals (mean, 8.7105 copies/ml; range, 2.6104–
2.5106); however, this difference was not statistically signiﬁcant
(p¼0.07).
Quantiﬁcation of the STLV-1 proviral load showed an average of
4.49 copies per 100 PBMC (range, 0.12–12.1) in the STLVþ group
and 6.44 copies (range, 0.03–42.6) in SIVþ/STLVþ mandrills
(Fig. 2B). The difference between the two groups was not statis-
tically signiﬁcant (p¼0.23), but it is interesting that the highest
proviral load value was found in the co-infected group.
We showed previously that STLV-1 in mandrills is integrated
into both CD4þ and CD8þ T cells (Souquiere et al., 2009a). We
found no signiﬁcant difference in the proviral load in CD4þ and
CD8þ T cells in STLVþ and SIVþ/STLVþmandrills (Fig. S1).
Dually infected mandrills have fewer CD4þ T cells
Although SIV and STLV infections do not appear to inﬂuence
CD4þ and CD8þ T cells in mandrills independently, co-infection
places greater pathogenic pressure on the immune system, which
may modify the proportions of T cells. We evaluated the effect of
retroviral infection by assessing the absolute numbers and per-
centages of CD4þ and CD8þ T cells in the four groups. As shown in
Fig. 3A, the percentage of CD4þ T cells in SIVþ/STLVþ animals
(average, 1174.7%) was signiﬁcantly lower than that in the control
group (21.776.2%; po0.01), in the SIVþ group (17.579%;
po0.05) and in the STLVþ group (18.377.1%; po0.01). The
values for the SIVþ group were also signiﬁcantly lower than in
the control group. In absolute numbers, the values were signiﬁ-
cantly lower in the SIVþ/STLVþ group (mean, 2357207 cells/mm3)
than in the control (4757315 cells/mm3) and the SIVþ group
Table 1
Distribution of mandrills in the four studied groups.
Sex Uninfected STLV-1
infected
SIV
infected
STLV/SIV
co-infected
Total
Males 20 11 21 9 61
Females 38 8 17 4 67
Total 58 19 38 13 128
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(5007372 cells/mm3) (po0.001) (Fig. 3B). In all groups, some
mandrills had an absolute CD4þ T cell numbero50/mm3.
Signiﬁcantly higher percentages of CD8þ T cells (Fig. 3C) were
found in SIVþ (average, 3379.4%) and STLVþ groups (32.776.3%)
than in the control group (28.377.9%; po0.05). Evaluation of the
absolute numbers of CD8þ T cells conﬁrmed that the highest
number was in SIVþ mandrills (8987555 cells/mm3), which was
signiﬁcantly higher than in the control group (5897354 cells/mm3)
and the STLVþ group (5617285 cells/mm3) (po0.05) (Fig. 3D).
No signiﬁcant difference in the number of CD8þ T cells was found
in the SIVþ/STLVþ group (Fig. 3C and D).
Dual infection and circulating naive, central memory and effector
memory CD4þ and CD8þ T cells
We next sought to determine whether retroviral infection is
associated with speciﬁc changes in the proportions of circulating
naive, central memory and effector memory CD4þ and CD8þ T
cells. Characterisation of these three subsets in CD4þ and CD8þ T
cells has been reported for macaques (Pitcher et al., 2002), African
green monkeys (Pandrea et al., 2006), sooty mangabeys (Sumpter
et al., 2007) and mandrills (Apetrei et al., 2011). These studies
indicate that the subsets can be deﬁned from the CD28/CD95
Table 2
Immunological and virological parameters of mandrill A and mandrill T compared to 58 uninfected mandrills.
Mandrill T Mandrill A Uninfected mandrills
(Mean of 58)
Age (years)/Sex 12/M 20/M 10.676.5
Natural infections Yes Yes –
Age of infection SIV (years) 3 Unknown –
Age of Infection STLV (years) 5 Unknown –
SIVmnd-1 viral load (RNA copies/ml) 1.3105 1.2106 –
STLV proviral load in total PBMC (%) 22.5 42.6 –
STLV proviral load in CD4þ T cells (%) 23.8 74.7 –
STLV proviral load in CD8þ T cells (%) 35.3 33.5 –
Absolute number of CD4þ T cells (/mm3) 224 184 4767315
% HLADR in CD4þ T cells 18.6 67.2 4.272.1
% HLADR in CD8þ T cells 22.6 62.5 8.274.2
% Ki67 in CD4þ T cells 3.7 13.5 4.372
% Ki67 in CD8þ T cells 2.6 13.1 3.672.4
% CD25 in CD4þ T cells 41.9 87 20.978.2
% CD25 in CD8þ T cells 12.3 35.5 9.675.4
Cytokines Th1 (pg/ml) Mean of 21
IL-2 6.1 1.3 5.876.4
IFN-γ 375 154 2457243
TNF-α 39 17 13.3718.9
Cytokines Th2 (pg/ml)
Il-4 2.8 0.9 1.972.2
Il-5 2.1 0.6 2.672.5
Il-6 7.8 3.7 4.373.6
Haematological anomaly Presence of ﬂower cells Persistent hyper-eosinophilia:
44800/mm3 presence of ﬂower cells
–
Pathology Infective dermatitis Scabies resistant to therapy –
Fig. 1. Clinical manifestations observed in two SIVþ/STLVþ co-infected mandrills. (A) Dermatitis was observed in mandrill T and (B) scabies in mandrill A.
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pattern of staining. We found no signiﬁcant differences in the
proportions of naive CD4þ T cells (Fig. 4A) or of central or effector
memory cells (data not shown).
SIV infection decreased the proportion of naive CD8þ T cells
below that of the control group (po0.001) (Fig. 4B). Co-infection was
associated with a decrease in the proportion of naive cells (po0.001)
and an increase in that of central memory cells (po0.05) (Fig. 4B and
C, respectively); no difference was observed in the proportion of
effector memory CD8þ T cells (Fig. 4D).
Although SIV infection appears to affect naive T cells, SIV and
STLV infections do not appear to cause major changes in the
distribution of the T cell repertoire.
Do retroviral infections perturb the activation and proliferation of
CD4þ and CD8þ T cells?
In a previous study, we demonstrated increased activation
of CD4þ T cells in mandrills naturally infected with STLV-1
(Souquiere et al., 2009b). Others have shown that T-cell activation
and proliferation do not increase signiﬁcantly during chronic SIV
infection in mandrills (Apetrei et al., 2011). We therefore investi-
gated whether mono and dual retroviral infections induce T cell
activation and perturb their proliferative capacity.
The fractions of proliferating CD4þ and CD8þ T cells clearly
varied signiﬁcantly with infection. As seen in Fig. 5A, a lower
percentage of Ki67 was found in CD4þ T cells from SIVþ animals
and higher values in the STLVþ group. Proliferation was weaker in
the SIVþ group than in the other three groups (po0.01), and that
in the STLVþ group was higher than in the control group (po0.05)
and the SIVþ group (po0.01). SIV infection appeared to have
a negative effect on CD8þ T cells (Fig. 5B), as the value in the
SIVþ group was lower than in the controls, the STLVþ group
(po0.01) and also the SIVþ/STLVþ group (po0.05). However, if
we exclude the two co-infected monkeys that developed diseases,
the difference with the SIVþ/STLVþ group was no longer statisti-
cally signiﬁcant.
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(B) STLV proviral load in PBMCs of mandrills infected with STLV (Δ) and co-infected with STLV and SIV (◊) (per 100 PBMC). Mann-Witney test used for statistical analysis of each
T-cell subset.
**
**
*
**
Uninfected SIV+ STLV+ SIV+/STLV+
0
5
10
15
20
25
30
35
40
%
 C
D
4+
T 
ce
lls
Median 
25%-75% 
Min-Max 
Data
*
*
0
10
20
30
40
50
60
%
 C
D
8+
T 
ce
lls
Uninfected SIV+ STLV+ SIV+/STLV+
**
**
0
200
400
600
800
1000
1200
1400
1600
1800
# 
C
D
4+
T 
ce
lls
Uninfected SIV+ STLV+ SIV+/STLV+
**
**
0
500
1000
1500
2000
2500
3000
3500
# 
C
D
8+
T 
ce
lls
Uninfected SIV+ STLV+ SIV+/STLV+
Fig. 3. T-cell subsets in blood from four groups of mandrills. Mandrills infected with STLV (Δ), SIV (□), STLV and SIV (◊) and uninfected (○). (A) Percentages of CD3þCD4þ
cells. (B) Absolute numbers of CD4þ T cells. (C) Percentages of CD3þCD8þ cells. (D) Absolute numbers of CD4þ T cells. Mann-Witney test used for statistical analysis of
each T-cell subset. Signiﬁcance assumed at po0.05.
S. Souquière et al. / Virology 454-455 (2014) 184–196 187
Interestingly, we found a direct correlation between the
expression of Ki67 and STLV proviral load in CD4þ T cells in the
STLVþ and SIVþ/STLVþ groups (Fig. 5C and D). Taken together,
these data suggest that STLV and SIV infections have different
effects on the proliferation of CD4þ T cells.
We also evaluated the activation of CD4þ and the CD8þ T cells
using expression of HLA-DR markers. In a previous study
(Souquiere et al., 2009b), we showed that natural STLV infection
in mandrills is associated with an increase in the activation of
CD4þ T cells. In the present study, we found no difference in HLA-
DR expression in CD4þ and CD8þ T cells in the SIVþ group,
whereas the SIVþ/STLVþ group had higher percentages of HLA-
DR in CD4þ and CD8þ T cells than the other groups (po0.01)
(Fig. 6A and B). As the relevance of this marker has not been
established in mandrills, we also evaluated the release of neop-
terin to conﬁrm immune activation. Neopterin biosynthesis is
closely associated with activation of the cellular immune system,
and increased concentrations have been reported in patients with
viral infections (Mildvan et al., 2005; Murr et al., 2002). We found
a positive correlation between the expression of HLA-DR in CD8þ
T cells and secretion of neopterin in plasma only in the SIVþ/
STLVþ group (Fig. 6C).
Thus, co-infection signiﬁcantly increases cell activation and
proliferation in mandrills.
Do dual retroviral infections modify the immune regulation of T cells?
One of the characteristics of adult T-cell leukaemia/lymphoma
is the presence of abnormal lymphocytes that express CD25, and
CD4 and CD8 T cells expressing the CD25 marker have been shown
to be the reservoir of HTLV-1 (Nagai et al., 2001; Yamano et al.,
2004). Furthermore, CD4þCD25þ T cells, especially the Treg sub-
population with immunosuppressive functions, can be disrupted
by HTLV, resulting in immunodeﬁciency (Yamano et al., 2005;
Yano et al., 2007). In cases of co-infection with HIV, the number of
CD4þCD25þ T cells decreased progressively, eliminating the Treg
cell suppressor function and resulting in immune hyperactivation
(Eggena et al., 2005).
To assess the effect in mandrills, we ﬁrst evaluated the
percentages of CD25þ in CD4þ and CD8þ T cells. In CD4þ T cells,
expression of CD25þ was signiﬁcantly higher in the SIVþ/STLVþ
group than in the control (po0.01) and the STLVþ groups
(po0.05); for the STLVþ group, the ﬁnding was no longer
signiﬁcant after removal of the extreme value for mandrill A. No
signiﬁcant difference was found from the SIVþ group (Fig. 7A). No
difference among the groups was found in the percentage of CD25
in CD8þ T cells (data not shown).
The signiﬁcance of CD25þ expression in humans is uncertain,
even though it is used in the phenotypic deﬁnition of Treg because
it is strongly induced by the HTLV-1 Tax protein (Cross et al., 1987;
Inoue et al., 1986). The marker used currently to deﬁne Treg cells is
the forkhead transcription factor FoxP3 (Fontenot et al., 2003; Hori
et al., 2003). Therefore, to determine the role of CD4þ Treg cells
precisely, we evaluated FoxP3 expression in CD25þCD4þ T cells.
As shown in Fig. 7B, no signiﬁcant difference was found among the
groups.
Collectively, these results suggest that dual infection with SIV
and STLV induces the activation mechanism in CD4þ T cells rather
than establishing a regulatory system.
Characterisation of an STLV cell line derived from a co-infected
mandrill
Lymphocytes enriched with CD4þ T cells from mandrill A were
cultivated as described previously (Souquiere et al., 2009a), and
HTLV-1 P19 antigen and SIV reverse transcriptase were evaluated
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at various times after culture. After 7 days of culture, p19 protein
was detected in the supernatant, and evidence of SIV reverse
transcriptase activity was found (Fig. 8A). After 6 months of
culture, a continuous cell line was obtained, with extensive
HTLV-1 P19 antigen production in the supernatant but with no
evidence of SIV replication. After 6 months of culture, tax/rex
mRNA was detected in each cell at a mean of two copies of
provirus STLV (data not shown).
A study of clonality in the cell line by linker-mediated PCR
showed nine integration sites, three of which predominated
(Fig. 8B). Our cell line, showed atypical morphology, with dendritic
expansion (Fig. 8C). Electron microscopy conﬁrmed the morpho-
logy and the production of STLV particles (Fig. 8D). To better
characterise these cells, we performed ﬂow cytometry with a
panel of antibodies at various culture times. After 21 days, the
majority of cells were CD3þ and some expressed CD40, CD83 and
CD86; they did not express CD11c or CD123 (Fig. 9A). After
6 months of culture, the phenotype indicated the absence of CD3
expression, and the majority of cells expressed CD40, CD83, CD86
and CD123 (Fig. 9B). A unique plasmacytoid dendritic cell (pDC)
line was derived from a patient with pDC leukaemia (GEN cell line;
patent 02–15927) (Chaperot et al., 2001). Our ﬁndings indicate
that the phenotype of the cell line corresponds to a pDC lineage,
which is immortalised and produces STLV particles.
Discussion
We report here the results of a clinical, virological and immu-
nological survey of SIV and STLV co-infection in 128 mandrills,
representing the largest study of multiple lentiviral infections
performed in mandrills.
Mandrills are known to have a high level of SIV replication, and
they are natural hosts of SIV (for review, see Pandrea et al., 2008).
We conﬁrmed previously that STLV infection is characterised by a
variable proviral load in infected animal (Souquiere et al., 2009b).
We next investigated the effect of co-infection on CD4þ and
CD8þ T cells. SIV and STLV mono-infected groups had elevated
CD8þ T cell levels, and animals with SIV infection showed
moderate depletion of CD4þ T cells. These results conﬁrm those
of previous studies in naturally SIV-infected sooty mangabeys and
mandrills (Sumpter et al., 2007; Apetrei et al., 2011) and our
results in mandrills naturally infected with STLV (Souquiere et al.,
2009b). From the expression of CD28 and CD95 in T cells, we
established that SIV and STLV had no effect on the distribution of
CD4þ TN, TM or TE cells; only SIV infection (either alone or with
STLV co-infection) decreased the number of CD8þ TN cells, as
observed previously (Apetrei et al., 2011). Interestingly, co-
infection tended to lower the number of CD4þ T cells. This implies
that co-infection involves two mechanisms, due to both SIV and
STLV, targeting CD4þ T cells and ﬁnally leading to depletion. Both
SIV and STLV-1 integrated in CD4þ and CD8þ T cells preferentially
target CD4þ T cells.
Perturbation of CD4þ T cells in uninfected primate models is
not clearly understood, but there is evidence that SIV is deleterious
for these cells in vitro. The mechanism of action of STLV-1 has not
yet been studied, but, as it is the simian counterpart of HTLV-1,
some parallels could be drawn. Thus, in HTLV-1 infections, the
viral genes Tax and HBZ are thought to play important roles in
pathogenesis. Tax potently promotes the expression of its own
viral genes and also stimulates the transcription of cellular genes,
including cytokines (e.g. IL2), cytokine receptors (IL2Rα) and anti-
apoptotic genes (Yoshida, 2001). In addition, by binding to other
protein complexes, Tax represses the transcription of genes
involved in negative control of the cell cycle, activation of
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apoptosis and DNA repair. The effect of these properties is that T
cells accumulate DNA mutations, resulting in transformation and
monoclonal expansion (Jeang et al., 2004).
In the present study, expression of CD25 in CD4þ T cells was
enhanced in co-infected animals. We demonstrated previously
that CD25 in CD4þ T cells was correlated with STLV proviral load
(Souquiere et al., 2009b), which was conﬁrmed in this study in the
STLVþ and SIVþ/STLVþ groups. This ﬁnding is in accordance with
the fact that Tax protein activates the transcription of gene coding
for CD25 (Yoshida, 2001) in HTLV-1 infection, which could explain
the increase in this subset of cells.
As Treg have been identiﬁed among CD4þ T cells expressing
CD25 in humans (Fehervari and Sakaguchi, 2004), it could be
hypothesised that the increased activation involves generation of
more Treg cells. We did not, however, conﬁrm this with FOxP3
expression in CD4þCD25þ T cells. There is no direct evidence that
all Treg cells express FoxP3 in mandrills, however, as in humans
(Mori et al., 1996; Thompson and Powrie, 2004). In particular,
Yamano et al. (2005) demonstrated the role of Tax in decreased
expression of FoxP3 mRNA in CD4þCD25þ T cells. Further inves-
tigations are needed to determine the mechanism of overexpres-
sion of CD25 in mandrills.
We found that proliferation was increased and positively
correlated with STLV proviral load in both the group infected with
STLV and in the co-infected group. This implies that STLV integra-
tion also affects proliferation of T cells, as established in humans
(Nicot, 2005). We further showed a direct correlation between
the proviral load in CD4þ T cells and their proliferative capacity
in vivo. In humans infected with HTLV, Asquith et al. (2007)
demonstrated a correlation between Tax expression and proliferation
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of CD4þ CD45ROþ (the CD4þ T cell memory subset in humans)
in vivo.
STLV infection, but not SIV infection, in mandrills clearly involves
increased activation and proliferation of T cells. Activation and
proliferation phenomena are particularly important in understanding
the pathogenesis of SIV. It was reported recently that limited
activation and proliferation protect the natural SIV host (Silvestri
et al., 2003; Paiardini et al., 2006; Sumpter et al., 2007). In our study,
co-infected animals showed signiﬁcantly increased activation of
T cells, as conﬁrmed by the presence of neopterin. Thus, STLV appears
to perturb the immune system, while SIV plays the role of a delete-
rious cofactor.
Two co-infected mandrills in this study had pathological
manifestations, infective dermatitis and scabies, that are unusual
in our colony. Both conditions have been associated with HTLV
infection in endemic zones (Bittencourt et al., 2006; Blas et al.,
2005; Brites et al., 2002; LaGrenade et al., 1995; Mahé et al., 2004).
As we saw no clinical signs in mandrills naturally infected with
STLV in a previous study (Souquiere et al., 2009b), we hypothesise
that the development of these conditions was due to the
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co-infection. The two monkeys had high STLV proviral loads, but
their SIV load was no different from that of controls. An elevated
proviral load of HTLV is known to enhance the risk for disease in
humans (Casseb et al., 2008; Gabet et al., 2003). We demonstrated
previously that the duration of infection of mandrills is correlated
with an increase in integrated virus (Souquiere et al., 2009b). The
dates of infection were unknown for the mandrill with scabies,
which died 3 months after its arrival; necropsy showed chronic
granulomatousm eosinophilic serositis and generalised amyloido-
sis. Mandrill T, which had infective dermatitis, had been infected
with STLV 5 years previously, which can be considered recent.
Three years previously, however, this monkey was also infected
with SIV, which may have perturbed immune control. Consistent
with this observation, we examined the evolution of its proviral
load during the past 5 years (Fig. 10) and found that the increase
corresponded to the date of co-infection with SIV. This implies
that in the primo-infection state moderate activation and prolif-
eration due to SIV could promote clonal expansion of STLV-
infected T cells. Most importantly, disease occurred concomitantly
with co-infection by SIV. CD4þ T cells were not depleted in these
animals, with numbers in the normal range. During a survey of
sooty mangabeys, two animals were found to have fewer than
50 cells/mm3 CD4þ T cells (Sumpter et al., 2007); however, these
two animals did not develop disease, and no activation or
proliferation was evident. In our study, several mandrills in all
groups had low CD4þ T cell numbers; all were characterised only
by old age and were healthy. This implies that the number of CD4þ
T cells is not a criterion of immunodeﬁciency in nonhuman
primates, as it is for HIV and SIV infection in human and macaques
(Gordon et al., 2008; Klatt et al., 2008; Milush et al., 2007). The
level of immune activation in our study was the highest ever
reported in this species, indicating that high immune activation
exists in African nonhuman primates. Nevertheless, none of these
factors, which are unusual in mandrills, affected the overall
number of CD4þ T cells or the level of SIV replication. Examination
of the IFNγ response to the entire overlapping Tax gene in the two
mandrills that developed disease showed results comparable to
those in mandrills infected only with STLV (Souquiere et al.,
2009b). No particular peptide in the Tax region appeared to be
the target for the cellular response in these mandrills (Fig. S2), and
no correlation was found between the STLV proviral load and the
level of cell response to the Tax protein.
We also assessed immortalised cell lines from mandrills co-
infected with SIV and STLV. Those from STLV-infected animals
have a CD4þ T cell phenotype that produces STLV virions and
expresses Tax mRNA (Souquiere et al., 2009a). After 6 months,
however, we identiﬁed a new population of cells, which produced
only STLV, with no trace of SIV. Moreover, the morphology and
immunophenotyping strongly suggested that this cell line consists
of pDCs. Our pDC line was grown in the presence of IL-2, which
appears to be necessary to modulate its activation and survival
(Naranjo-Gomez et al., 2007). It is difﬁcult to explain this phe-
nomenon. Only a few pDCs are present in the bloodstream; for
example, only one pDC line was obtained from tumour cells from a
patient with an unclassiﬁed leukaemia (Chaperot et al., 2001).
Therefore, complex events must have to occur in order to produce
such cells.
The mandrill with generalised scabies presented some biologi-
cal anomalies. First, co-infection induced replication of SIV in vitro,
which involved the destruction of most CD4þ T cells and made
expansion of these cells at term impossible: 74.7% of the CD4þ-
enriched cells used for cell culture were infected with STLV. This
implies that CD4þ T cells can produce a large amount of STLV-free
virions in the ﬁrst phase of culture. In the HTLV model, primary
dendritic cells are very permissive to HTLV virions (Jones et al.,
2008). We therefore assume that pDCs frommandrills have similar
properties with regard to STLV and can also produce free virions.
This raises the possibility that STLV also uses pDCs to infect target
cells in vivo efﬁciently. This mandrill also had a high level of
eosinophils in its blood, and eosinophils have been reported to
induce maturation of dendritic cells (Lotﬁ and Lotze, 2008). These
observations are consistent with a disorder in the performance of
dendritic cells, in addition to the effects of HTLV itself (Hishizawa
et al., 2004; Makino et al., 2000). Further investigations will reveal
the exact mechanisms of pDC infection in mandrills.
In conclusion, our study shows that retroviral infection can
induce immune disturbances in mandrills, especially after co-
infection with SIV, which increases activation of the immune
system, leading to disease. Dual infections are not rare. Data
obtained by our laboratory show that 85% of wild mandrills living
in the Lopé reserve in the centre of Gabon are carriers of both
infections (Makuwa et al., 2004; Souquiere et al., 2001). In this
study, however, STLV infection was the initial infection in almost
all cases of co-infection. As we have shown previously, STLV
infection can increase immune activation under certain conditions
and thus lead to disease conditions that are worsened by co-
infection with SIV. SIV can therefore be considered a cofactor in
the development of disease related to STLV in mandrills. Moreover,
as we have clearly demonstrated, activation and proliferation
determine the development of disease, independently of the
number of CD4þ T cells.
These ﬁndings lead to reconsideration of the effect of multiple
retroviral infections in non-human primates. Many questions arise
about the interactions in the same host between an oncovirus
(STLV) with proliferative properties and a lentivirus (SIV) that is
intrinsically deleterious for each CD4 cell. Further studies are
needed to explore the mechanisms by which STLV increases
proliferation and activation of T cells in mandrills and what occurs
in the presence of SIV.
Materials and methods
Ethics statement
The animals were handled in accordance with standard national
operating procedures in the Centre International de Recherches
Médicales de Franceville (CIRMF), in accordance with the United
States National Institutes of Health guidelines for the Care and Use of
Laboratory Animals and in accordance with the recommendations of
a working group chaired by Sir David Weatherall in December 2006.
The animal protocols and procedures were approved by the
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Gabonese ethics committee for animal experimentation at the
CIRMF, and registered under No. CE0 08-006 CIRMF. The housing
conditions are in strict accordance with European Union guidelines
for animal care (European Union Directive 86/609/EEC). The primate
centre has three veterinarians specialized in primates – an etholo-
gist, a primatologist and an ecologist, and all experiments were
conducted under their supervision. Each primate housed in the
CIRMF Primate Centre has an annual health check under anaesthesia
(ketamine at 10 mg/kg body weight). The blood samples taken for
this study were collected under strict health control by Primate
Centre veterinarians.
Specimen collection
Blood samples from SIVmnd- and STLV-1-positive mandrills
were collected in EDTA K2 tubes under ketamine-HCl and used
for ﬂow cytometry. Peripheral blood mononuclear cells (PBMCs)
were isolated by Ficoll-Hypaque gradient centrifugation (Sigma-
Aldrich), and plasma was centrifuged at 3000 g for 10 min,
dispensed into 1-ml aliquots and frozen at –80 1C.
Serological screening
Plasma from mandrills was screened for the presence of HTLV-
1/2 antibodies by two enzyme-linked immunosorbent assays (ELI-
SAs), HTLV-1 Platelia New (Biorad, Marnes-la-Coquette, France) and
Vironostica (Biomerieux, Marcy l'Etoile, France). HTLV-1 infection
was conﬁrmed by western blot (HTLV blot 2.4, Genelabs Diagnos-
tic). A peptide-based ELISA was used to detect antibodies against
SIVmnd-speciﬁc peptides mapping the V3 region of the env
glycoproteins (Simon et al., 2001). SIV infection was conﬁrmed by
western blot HIV-2 (New LAV-Blot II, Biorad, Marnes-la-Coquette,
France).
Flow cytometry for surface and intracellular markers
Four-colour ﬂow cytometry was performed on whole blood
according to the standard procedure. The monoclonal antibodies
used were CD4-ﬂuorescein isothiocyanate (FITC) (clone MT4-77),
HLA DR-phycoerythrin (PE) (clone G46-6), CD25-PE (clone 2A3),
CD3-allophycocyanin (APC) (clone SP34-2), CD8-peridine chloro-
phyll protein (PerCP) (clone SK1), CD28-PE (clone L293) and CD95-
FITC (clone DX2) (all from BD Bioscience, Le Pont de Claix, France).
For intracellular staining, CD4-PE (clone L200), CD3-APC (clone
SP34-2), CD8-PerCP (clone SK1) and Ki67-FITC (clone B56) were
used. Flow cytometric acquisition was performed on at least
10,000 events in lymphocyte squares on a FACScalibur ﬂow cyto-
meter driven by the CellQuest software package (Becton Dickinson,
Heidelberg, Germany). The acquired data were analysed with
FlowJo software v7.2 (Tree Star, Inc., Ashland, Oregon, USA).
Immunophenotyping of the STLV-1 cell line
Cells were sampled on day 21 and month 6 of culture. After
washing in phosphate-buffered saline 0.1% bovine serum albumin
buffer, cells were stained with CD3-APC (clone SP34-2), CD25-PE
(clone 2A3), CD83-PE (clone HB15e), CD86-FITC (clone 2331),
CD11c-APC (clone S-HCL-3) and CD123-PE (clone 7G3) (all from
BD Bioscience) and CD40-PE (clone MAB89) (Immunotech, Mar-
seille, France).
Clonality of cell lines
The clonality of STLV-1-infected cell lines (sampled at 6 months)
was assessed by the sensitive quadruplicate elongation-mediated
polymerase chain reaction (linker-mediated PCR) method described
elsewhere (Cavrois et al., 1996; Leclercq et al., 1999).
Isolation of CD4þ and CD8þ T cells
Peripheral blood lymphocytes were separated by Ficoll gradient
density centrifugation. Negative depletion was performed on 10
million lymphocytes with magnetic beads coupled to CD4 or CD8
antibody, as recommended by the manufacturer (Dynabeads,
Invitrogen Dynal, Oslo, Norway). The phenotype of depleted cells
was conﬁrmed by three-colour ﬂow cytometry with monoclonal
antibodies CD4-FITC (clone MT4-77), CD3-APC (clone SP34-2) and
CD8-PerCP (clone SK1).
Cell culture
After washing, the remaining CD4þ- and CD8þ-enriched cells
were suspended in RPMI 1640 growth medium (Cambrex
Bioscience, Walkersville, Maryland, USA) supplemented with 20%
heat-inactivated foetal bovine serum (Gibco BRL, Eragny, France),
1% penicillin–streptomycin mixture (Gibco BRL, Eragny, France), 1%
L-glutamine 200 mmol/l (Gibco BRL, Eragny, France) and 20 U/ml
human recombinant IL-2 (Roche Diagnostics, Mannheim, Ger-
many). The lymphocytes were stimulated with 3 mg/ml of the
mitogen concanavalin-A (Sigma-Aldrich, Saint Quentin Fallavier,
France) and then incubated at 37 1C in 5% CO2. To maintain the
cells, 90% of the medium was changed twice a week.
SIV reverse transcriptase determination and HTLV-1 P19 antigen
detection
Reverse transcriptase (RT) activity produced by SIV was quan-
tiﬁed in supernatant with the Lenti-RT kit (Cavidi Tech AB,
Uppsala, Sweden), as recommended by the manufacturer. The
kinetics of STLV production was determined by detection of P19
antigen in supernatant with the Retrotek HTLVI/II p19 Antigen
ELISA kit (ZeptoMetrix Corp.) according to the manufacturer's
instruction. The concentrations of P19 in specimens were deter-
mined by interpolation from a standard curve.
Electron microscopy
STLV cells line were ﬁxed in glutaraldehyde and then in
osmium tetroxide and embedded in epoxy resin. Thin sections
were stained with uracyl acetate and lead citrate and examined
under a JEOL 100 S electron microscope.
SIV viral load
RNAwas extracted from 150 ml of plasma with the QiaAmp viral
RNA mini kit (Qiagen, Courtaboeuf, France) and eluted in 50 ml of
Tris EDTA buffer, as recommended by the manufacturer. Quanti-
ﬁcation was performed by real-time SYBR Greens RT-PCR as
described previously (Souquiere et al., 2009c).
STLV proviral load determined with real-time PCR
DNA was extracted from PBMC with phenol/chloroform, and
STLV proviral loads were quantiﬁed by real-time PCR, as described
previously (Souquiere et al., 2009b). A standard curve was gener-
ated with the MT4 cell line containing seven copies of provirus
HTLV per cell by 10-fold serial dilutions. To standardise the cell
number, the albumin gene was quantiﬁed by the TaqMan PCR
method with iTaq Supermix and ROX (Biorad, Marnes-la-Coquette,
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France). The TaqMan Probe 5'FAM-CCTGTCATGCCCACACAAATC-
TCTCC-TAMRA3' (ALBT) and the primers GCTGTCATCTCTTGTG-
GGCTGT (ALBF) and ACTCATGGGAGCTGCTGGTTC (ALBR) were
used as described previously (Souquiere et al., 2009b). The PCR
protocol consisted of 3 min at 95 1C, 50 cycles for 10 s at 95 1C and
45 s at 60 1C. The results for the STLV proviral load are presented
as copy number per 100 cells.
Detection of tax/rex mRNA by RT-PCR
Total cellular RNA was extracted from the cultured T cells with
the RNeasy Protect Mini Kit (Qiagen, Courtaboeuf, France). RT and
cDNA synthesis were determined as described previously (Kazanji,
2000). Immediately after cDNA synthesis, semi-nested PCR was
performed on the pX region, with RPX3 and RPX5 as the outer
primers and RPX3 and RPX4 as the inner primers (Kazanji, 2000;
Kinoshita et al., 1989). To conﬁrm the presence of ampliﬁable
cDNA in the cultured cells, a portion of glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) mRNA was ampliﬁed with primers
18SL (sense) and 20SL (antisense), as described previously
(Kazanji, 2000).
Neopterin assay
Neopterin in plasma was quantiﬁed with a commercial ELISA
kit (Neopterin ELISA, IBL-Hamburg GmbH, Hamburg, Germany)
according to the manufacturer's instructions. The concentrations
of neopterin in specimens were determined by interpolation from
a standard curve.
Detection of cytokine in plasma by the Luminex method
The Bio-Plex human cytokine 27-Plex assay was carried out
according to the manufacturer's instructions (Bio-Rad Laboratories,
Marnes-la-Coquette, France). A 50-ml volume of each plasma sample
(diluted four times in serum) and of the standard was added to a
96-well plate containing 50 ml of antibody-coated ﬂuorescent beads.
Biotinylated secondary and streptavidin-PE antibodies were added
to the plate with alternate incubation and washing. After the last
washing, 125 ml of assay buffer were added to the wells, and the
plate was incubated and read on the Bio-plex array reader, with a
5 PL regression curve to plot the standard curve. Samples and
controls were read at a low RP1 target setting (to maximise assay
sensitivity when the expected concentrations are o3200 pg/ml).
Data were analysed with Bioplex manager software, version 3. The
results are expressed in pg/ml.
Statistical analysis
For comparison of groups, Mann–Whitney U tests were per-
formed. Correlations between different sets of data for the same
group were analysed by either the standard Pearson correlation
coefﬁcient or the Spearman rank correlation test. Signiﬁcance was
assumed at po0.05. All analyses were performed with Statistica
software v7.1.
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